Related references
Note: Only part of the references are listed.Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?
Christian Cordano et al.
ANNALS OF NEUROLOGY (2021)
Epigallocatechin Gallate in Progressive MS A Randomized, Placebo-Controlled Trial
Rebekka Rust et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis A Randomized, Placebo-Controlled Trial
Judith Bellmann-Strobl et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome
Rafael de la Torre et al.
CLINICAL NUTRITION (2020)
Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy
Elias S. Sotirchos et al.
ANNALS OF NEUROLOGY (2020)
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis
Michael Dietrich et al.
BRAIN (2020)
Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Joseph Kuchling et al.
FRONTIERS IN NEUROLOGY (2020)
Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study
Rachel C. Nolan-Kenney et al.
ANNALS OF NEUROLOGY (2019)
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin et al.
LANCET NEUROLOGY (2019)
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Simon Faissner et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Contribution of normal aging to brain atrophy in MS
Christina J. Azevedo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Normative Data and Minimally Detectable Change for Inner Retinal Layer Thicknesses Using a Semi-automated OCT Image Segmentation Pipeline
Seyedamirhosein Motamedi et al.
FRONTIERS IN NEUROLOGY (2019)
Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis
Frederike C. Oertel et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study
Lisanne J. Balk et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2019)
Natural Polyphenols in the Treatment of Alzheimer's Disease
Syed-Badrul Syarifah-Noratiqah et al.
CURRENT DRUG TARGETS (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome
Hanna G. Zimmermann et al.
JAMA NEUROLOGY (2018)
Optical coherence tomography as a means to characterize visual pathway involvement in multiple sclerosis
Carla A. Wicki et al.
CURRENT OPINION IN NEUROLOGY (2018)
Multicenter reliability of semiautomatic retinal layer segmentation using OCT
Timm Oberwahrenbrock et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Axel Petzold et al.
LANCET NEUROLOGY (2017)
Imaging outcome measures for progressive multiple sclerosis trials
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Disease-modifying therapies modulate retinal atrophy in multiple sclerosis A retrospective study
Julia Button et al.
NEUROLOGY (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Imaging outcome measures for progressive multiple sclerosis trials
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis
Benjamin Knier et al.
BRAIN (2016)
Therapeutic effects of EGCG: a patent review
Leewanshi Chakrawarti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis
Dayong Wu
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study
Lisanne J. Balk et al.
JOURNAL OF NEUROLOGY (2016)
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
Rafael de la Torre et al.
LANCET NEUROLOGY (2016)
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
Andres Cruz-Herranz et al.
NEUROLOGY (2016)
Disease modifying therapies for relapsing multiple sclerosis
Dean M. Wingerchuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Disease modifying therapies for relapsing multiple sclerosis
Dean M. Wingerchuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The topographical model of multiple sclerosis A dynamic visualization of disease course
Stephen C. Krieger et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial
Anja Maehler et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
Daniel Ontaneda et al.
LANCET NEUROLOGY (2015)
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Multiple sclerosis-a quiet revolution
Richard M. Ransohoff et al.
NATURE REVIEWS NEUROLOGY (2015)
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
S. Schippling et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Early CNS neurodegeneration in radiologically isolated syndrome
Christina J. Azevedo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Dynamic formation of macular microcysts independent of vitreous traction changes
Alexander U. Brandt et al.
NEUROLOGY (2014)
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE
Quanye Sun et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
Timm Oberwahrenbrock et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis
Falko Kaufhold et al.
PLOS ONE (2013)
Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications
Munkyong Pae et al.
FOOD & FUNCTION (2013)
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?
Anja Mähler et al.
EPMA Journal (2013)
Epigallocatechin-3-Gallate Ameliorates Experimental Autoimmune Encephalomyelitis by Altering Balance among CD4+ T-Cell Subsets
Junpeng Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis
Stephanie B. Syc et al.
BRAIN (2012)
Microcystic macular oedema in multiple sclerosis is associated with disease severity
Jeffrey M. Gelfand et al.
BRAIN (2012)
nparLD: An R Software Package for the Nonparametric Analysis of Longitudinal Data in Factorial Experiments
Kimihiro Noguchi et al.
JOURNAL OF STATISTICAL SOFTWARE (2012)
Green tea EGCG, T cells, and T cell-mediated autoimmune diseases
Dayong Wu et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
Shiv Saidha et al.
LANCET NEUROLOGY (2012)
Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients
Pawel Bogdanski et al.
NUTRITION RESEARCH (2012)
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Prejaas Tewarie et al.
PLOS ONE (2012)
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes
Jeffrey M. Gelfand et al.
PLOS ONE (2012)
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography
Timm Oberwahrenbrock et al.
MULTIPLE SCLEROSIS INTERNATIONAL (2012)
Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
Katja Herges et al.
PLOS ONE (2011)
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
Ari J. Green et al.
BRAIN (2010)
Using retinal architecture to help characterize multiple sclerosis patients
Fiona Costello et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2010)
Distribution and biosynthesis of flavan-3-ols in Camellia sinensis seedlings and expression of genes encoding biosynthetic enzymes
Hiroshi Ashihara et al.
PHYTOCHEMISTRY (2010)
Primary-progressive multiple sclerosis (vol 6, pg 903, 2007)
D. Miller et al.
LANCET NEUROLOGY (2009)
Multiple sclerosis: An immune or neurodegenerative disorder?
Bruce D. Trapp et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Primary-progressive multiple sclerosis
David H. Miller et al.
LANCET NEUROLOGY (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers
U Ullmann et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2004)
Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis
O Aktas et al.
JOURNAL OF IMMUNOLOGY (2004)
Share Paper
